JOHN KIRKWOOD to Patient Safety
This is a "connection" page, showing publications JOHN KIRKWOOD has written about Patient Safety.
Connection Strength
0.112
-
Expanded access programmes: patient interests versus clinical trial integrity. Lancet Oncol. 2015 Jan; 16(1):15-7.
Score: 0.086
-
Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma. J Clin Oncol. 2017 Dec 01; 35(34):3815-3822.
Score: 0.026